X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (24) 24
breast cancer (16) 16
female (14) 14
humans (14) 14
middle aged (13) 13
adult (12) 12
aged (12) 12
breast neoplasms - drug therapy (11) 11
chemotherapy (11) 11
index medicus (11) 11
obstetrics & gynecology (11) 11
cancer (10) 10
breast neoplasms - pathology (8) 8
trastuzumab (8) 8
further section (6) 6
hematology, oncology and palliative medicine (6) 6
medicine & public health (6) 6
antimitotic agents (5) 5
antineoplastic agents (5) 5
antineoplastic agents - therapeutic use (5) 5
cancer therapies (5) 5
review article · übersichtsarbeit (5) 5
treatment outcome (5) 5
women (5) 5
adjuvant treatment (4) 4
age factors (4) 4
aged, 80 and over (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
care and treatment (4) 4
cyclophosphamide (4) 4
disease-free survival (4) 4
hematology (4) 4
medizin (4) 4
open-label (4) 4
paclitaxel (4) 4
product development (4) 4
receptor, erbb-2 - analysis (4) 4
research (4) 4
skin and connective tissue diseases (4) 4
adjuvant chemotherapy (3) 3
adjuvant therapy (3) 3
analysis (3) 3
anthracyclines (3) 3
antibodies, monoclonal, humanized - adverse effects (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
breast neoplasms - chemistry (3) 3
breast neoplasms - mortality (3) 3
chemotherapy, adjuvant (3) 3
chemotherapy, adjuvant - methods (3) 3
dose-response relationship, drug (3) 3
drug administration schedule (3) 3
early breast cancer (3) 3
efficacy (3) 3
epirubicin (3) 3
follow-up studies (3) 3
further section · weitere sektionen (3) 3
internal medicine (3) 3
logistic models (3) 3
metastasis (3) 3
multicenter (3) 3
neoadjuvant therapy - methods (3) 3
neoplasm staging (3) 3
neutropenia (3) 3
neutropenia - chemically induced (3) 3
oncology, experimental (3) 3
pain medicine (3) 3
pertuzumab (3) 3
radiation therapy (3) 3
receptor, erbb-2 - metabolism (3) 3
risk factors (3) 3
safety (3) 3
survival (3) 3
therapy (3) 3
young adult (3) 3
abridged index medicus (2) 2
adjuvant setting (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
aromatase inhibitor (2) 2
body weight (2) 2
breast cancer, metastatic (2) 2
breast neoplasms - surgery (2) 2
clinical trials (2) 2
colony-stimulating factors (2) 2
consensus (2) 2
cyclophosphamide - administration & dosage (2) 2
docetaxel (2) 2
doxorubicin - administration & dosage (2) 2
education (2) 2
epirubicin - administration & dosage (2) 2
europe (2) 2
expertenplenum · expert discussion (2) 2
fluorouracil - administration & dosage (2) 2
follow-up (2) 2
health care sciences & services (2) 2
her-2/neu (2) 2
incidence (2) 2
infusions, intravenous (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 747 - 756
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9897, pp. 1021 - 1028
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 2, pp. 135 - 144
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 3, pp. 236 - 244
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 345 - 356
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 869 - 878
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 10, pp. 933 - 942
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10075, pp. 1195 - 1205
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 6/2013, Volume 139, Issue 3, pp. 779 - 787
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 4/2011, Volume 19, Issue 4, pp. 483 - 490
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2009, Volume 144, Issue 5, pp. 677 - 685
Summary Myelosuppression, particularly febrile neutropenia (FN), are serious dose-limiting toxicities that occur frequently during the first cycle of... 
Non-Hodgkin lymphoma | neutropenia | risk factors | chemotherapy | Non‐Hodgkin lymphoma | Chemotherapy | Risk factors | Neutropenia | CHEMOTHERAPY-INDUCED NEUTROPENIA | COLONY-STIMULATING FACTORS | PREDICTIVE MODEL | CHOP CHEMOTHERAPY | BREAST-CANCER | B-CELL LYMPHOMA | CANCER-PATIENTS | RELATIVE DOSE INTENSITY | PROGNOSTIC-SIGNIFICANCE | HEMATOLOGY | ELDERLY-PATIENTS | Lymphoma, Non-Hodgkin - immunology | Risk Assessment - methods | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Body Weight | Prevalence | Prognosis | Prospective Studies | Age Factors | Area Under Curve | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Recombinant Proteins | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Neutropenia - chemically induced | Colony-Stimulating Factors - therapeutic use | Doxorubicin - administration & dosage | Lymphoma, Non-Hodgkin - drug therapy | Prednisone - administration & dosage | Antibodies, Monoclonal, Murine-Derived | Prednisone - adverse effects | Europe | Rituximab | Logistic Models | Neutropenia - drug therapy | Antibodies, Monoclonal - administration & dosage | Adolescent | Vincristine - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Doxorubicin - adverse effects | Medical research | Care and treatment | Albumin | Non-Hodgkin's lymphomas | Preventive health services | Cyclophosphamide | Analysis | Medicine, Experimental | Macrophage colony stimulating factor | Medicine, Preventive | Cancer | Index Medicus | Haematological Malignancy
Journal Article